Cancer drug company CG Oncology Inc. priced its initial public offering above its estimated range and added three million shares to the deal in a bullish.
Solo GPs are widely viewed as being more vulnerable to the vicissitudes of a troublesome macroeconomic environment. But many say that what’s tough today has always been tough.
CG Oncology Begins IPO Effort For Bladder Cancer Drug (Pending:CGON) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.